{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:08:07Z","timestamp":1786986487501,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","award":["404614"],"award-info":[{"award-number":["404614"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","award":["T32DK007202"],"award-info":[{"award-number":["T32DK007202"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK117058"],"award-info":[{"award-number":["K23DK117058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008953","name":"Prometheus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008953","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cgh.2019.08.042","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:53:01Z","timestamp":1566906781000},"page":"1939-1948.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases"],"prefix":"10.1016","volume":"18","author":[{"given":"Nghia H.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5171-8475","authenticated-orcid":false,"given":"Jejo","family":"Koola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parambir S.","family":"Dulai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Sandborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-7269","authenticated-orcid":false,"given":"Siddharth","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.08.042_bib1","first-page":"s51","article-title":"Report: economic implications of inflammatory bowel disease and its management","volume":"22","author":"Mehta","year":"2016","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.cgh.2019.08.042_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib3","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cgh.2018.08.052","article-title":"Project Sonar: a community practice-based intensive medical home for patients with inflammatory bowel diseases","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.08.042_bib4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cgh.2018.02.015","article-title":"Annual burden and costs of hospitalization for high-need, high-cost patients with chronic gastrointestinal and liver diseases","volume":"16","author":"Nguyen","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.08.042_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.gastro.2017.09.052","article-title":"Population health management for inflammatory bowel disease","volume":"154","author":"Dulai","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/MIB.0000000000001121","article-title":"Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database","volume":"23","author":"Barnes","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/MIB.0000000000000325","article-title":"Racial disparities in readmission, complications, and procedures in children with Crohn's disease","volume":"21","author":"Dotson","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182900","article-title":"Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease","volume":"12","author":"Micic","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cgh.2019.08.042_bib9","first-page":"347","article-title":"Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: a national database study","volume":"23","author":"Poojary","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/codi.12267","article-title":"Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis","volume":"15","author":"Gu","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11605-014-2734-7","article-title":"Characterizing readmission in ulcerative colitis patients undergoing restorative proctocolectomy","volume":"19","author":"Hanzlik","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cgh.2019.08.042_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2019.08.042_bib13","first-page":"28","article-title":"All-cause hospitalizations for inflammatory bowel diseases: can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital","volume":"3","author":"Malhotra","year":"2016","journal-title":"Mil Med Res"},{"key":"10.1016\/j.cgh.2019.08.042_bib14","first-page":"141","article-title":"Predictors of hospital length of stay and 30-day readmission in patients with inflammatory bowel disease admitted with a flare","volume":"32","author":"Picardo","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol (Australia)"},{"key":"10.1016\/j.cgh.2019.08.042_bib15","doi-asserted-by":"crossref","first-page":"S-642","DOI":"10.1016\/S0016-5085(13)62378-1","article-title":"Factors associated with 30 day re-admission in inflammatory bowel disease","volume":"1","author":"Naik","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib16","doi-asserted-by":"crossref","first-page":"S-452","DOI":"10.1016\/S0016-5085(15)31525-0","article-title":"Predictors of 30 day readmission rates in inflammatory bowel disease patients after hospital discharge","volume":"1","author":"Israel","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib17","doi-asserted-by":"crossref","first-page":"S-218","DOI":"10.1016\/S0016-5085(17)31027-2","article-title":"Patients cared for in an integrated academic IBD practice have lower readmission rates: a key quality indicator","volume":"152","author":"Hudesman","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib18","doi-asserted-by":"crossref","first-page":"S-788","DOI":"10.1016\/S0016-5085(12)63057-1","article-title":"Factors associated with hospital readmissions in patients with inflammatory bowel disease (IBD)","volume":"1","author":"Blonski","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib19","doi-asserted-by":"crossref","first-page":"S-375","DOI":"10.1016\/S0016-5085(14)61352-4","article-title":"30 day readmissions rate and predictors of readmission in hospitalized patients with ulcerative colitis","volume":"1","author":"Feuerstein","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib20","doi-asserted-by":"crossref","first-page":"S790","DOI":"10.1016\/S0016-5085(17)32738-5","article-title":"Predicting 30-day readmission rate in inflammatory bowel disease (IBD) patients: performance of lace index","volume":"152","author":"George","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib21","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1016\/S0016-5085(17)31493-2","article-title":"Racial disparities in readmission rates, procedures and complications among adults with inflammatory bowel diseases","volume":"152","author":"Syal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.08.042_bib22","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.14309\/00000434-201610001-00578","article-title":"Creation of a novel prospectively based inflammatory bowel disease readmission index","volume":"111","author":"Rizk","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3109\/00365521.2015.1020862","article-title":"Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors","volume":"50","author":"Tinsley","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib24","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/MIB.0000000000000870","article-title":"Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations: a cohort study","volume":"22","author":"Law","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ajg.2012.343","article-title":"Hospital readmissions in patients with inflammatory bowel disease","volume":"108","author":"Hazratjee","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib26","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/MIB.0000000000001213","article-title":"Predictors of early readmission in hospitalized patients with inflammatory bowel disease","volume":"23","author":"Christian","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib27","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1097\/MIB.0000000000001242","article-title":"Inflammatory bowel disease: predictors and causes of early and late hospital readmissions","volume":"23","author":"Mudireddy","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib28","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/MIB.0000000000000537","article-title":"Risk factors for rehospitalization within 90 days in patients with inflammatory bowel disease","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib29","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1093\/ecco-jcc\/jju027.669","article-title":"Hospital readmissions in patients with inflammatory bowel disease: a UK single centre experience","volume":"9","author":"Chan","year":"2015","journal-title":"J\u00a0Crohn's Colitis"},{"key":"10.1016\/j.cgh.2019.08.042_bib30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/ibd\/izy297","article-title":"Index severity score and early readmission predicts increased mortality in ulcerative colitis patients","volume":"25","author":"Kruger","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ibd\/izx007","article-title":"Predicting hospitalization and outpatient corticosteroid use in inflammatory bowel disease patients using machine learning","volume":"24","author":"Waljee","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/bmjqs-2013-001901","article-title":"Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study","volume":"22","author":"Amarasingham","year":"2013","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.cgh.2019.08.042_bib33","first-page":"424","article-title":"Development and implementation of a real-time 30-day readmission predictive model","volume":"2014","author":"Cronin","year":"2014","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.cgh.2019.08.042_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamapediatrics.2016.4678","article-title":"A\u00a0quantitative, risk-based approach to the management of neonatal early onset sepsis","volume":"171","author":"Kuzniewicz","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.cgh.2019.08.042_bib35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41395-018-0272-8","article-title":"A\u00a0randomized controlled trial of TELEmedicine for Patients with Inflammatory\u00a0Bowel Disease (TELE-IBD)","volume":"114","author":"Cross","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41395-018-0417-9","article-title":"Fragmented care is prevalent among inflammatory bowel disease readmissions and is associated with worse outcomes","volume":"114","author":"Cohen-Mekelburg","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib37","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1097\/MIB.0000000000001242","article-title":"Inflammatory bowel disease: predictors and causes of early and late hospital readmissions","volume":"23","author":"Mudireddy","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib38","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/MIB.0000000000001213","article-title":"Predictors of early readmission in hospitalized patients with inflammatory bowel disease","volume":"23","author":"Christian","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib39","first-page":"28","article-title":"All-cause hospitalizations for inflammatory bowel diseases: can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital","volume":"3","author":"Malhotra","year":"2016","journal-title":"Mil Med Res"},{"key":"10.1016\/j.cgh.2019.08.042_bib40","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ajg.2012.343","article-title":"Hospital readmissions in patients with inflammatory bowel disease","volume":"108","author":"Hazratjee","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib41","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/MIB.0000000000000870","article-title":"Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations: a cohort study","volume":"22","author":"Law","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.08.042_bib42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3109\/00365521.2015.1020862","article-title":"Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors","volume":"50","author":"Tinsley","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.08.042_bib43","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/MIB.0000000000000537","article-title":"Risk factors for rehospitalization within 90 days in patients with inflammatory bowel disease","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519309176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519309176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:31:51Z","timestamp":1761543111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519309176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1542356519309176"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.08.042","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}